These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24061449)

  • 1. Detection of 4 benzodiazepines in oral fluid as biomarker for presence in blood.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    Ther Drug Monit; 2014 Apr; 36(2):252-6. PubMed ID: 24061449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected From Patients Admitted to Detoxification, After High and Repeated Drug Intake.
    Nordal K; Øiestad EL; Enger A; Christophersen AS; Vindenes V
    Ther Drug Monit; 2015 Aug; 37(4):451-60. PubMed ID: 25549207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of equivalent cutoff thresholds in blood and oral fluid for drug prevalence studies.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    J Anal Toxicol; 2014 Mar; 38(2):92-8. PubMed ID: 24451086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS.
    Kintz P; Villain M; Concheiro M; Cirimele V
    Forensic Sci Int; 2005 Jun; 150(2-3):213-20. PubMed ID: 15944062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an LC-MS/MS method for the simultaneous determination of 25 benzodiazepines and zolpidem in oral fluid and its application to authentic samples from regular drug users.
    Jang M; Chang H; Yang W; Choi H; Kim E; Yu BH; Oh Y; Chung H
    J Pharm Biomed Anal; 2013 Feb; 74():213-22. PubMed ID: 23245253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of drug concentrations between whole blood and oral fluid.
    Langel K; Gjerde H; Favretto D; Lillsunde P; Øiestad EL; Ferrara SD; Verstraete AG
    Drug Test Anal; 2014 May; 6(5):461-71. PubMed ID: 24039237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous analysis of 14 benzodiazepines in oral fluid by solid-phase extraction and LC-MS-MS.
    Ngwa G; Fritch D; Blum K; Newland G
    J Anal Toxicol; 2007 Sep; 31(7):369-76. PubMed ID: 17725884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS).
    Smink BE; Mathijssen MP; Lusthof KJ; de Gier JJ; Egberts AC; Uges DR
    J Anal Toxicol; 2006 Sep; 30(7):478-85. PubMed ID: 16959142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Dräger DrugTest 5000 in a Naturalistic Setting.
    Gjerde H; Clausen GB; Andreassen E; Furuhaugen H
    J Anal Toxicol; 2018 May; 42(4):248-254. PubMed ID: 29409046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of oxycodone concentrations in oral fluid.
    Moore C; Kelley-Baker T; Lacey J
    J Opioid Manag; 2012; 8(3):161-6. PubMed ID: 22798176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Nitrobenzodiazepines and Their 7-Amino Metabolites in Oral Fluid.
    Vindenes V; Strand DH; Koksæter P; Gjerde H
    J Anal Toxicol; 2016 May; 40(4):310-2. PubMed ID: 27013620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of benzodiazepines in oral fluid using LC-MS-MS.
    Moore C; Coulter C; Crompton K; Zumwalt M
    J Anal Toxicol; 2007; 31(9):596-600. PubMed ID: 18093420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
    Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
    Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
    Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
    Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device.
    Gjerde H; Mordal J; Christophersen AS; Bramness JG; Mørland J
    J Anal Toxicol; 2010 May; 34(4):204-9. PubMed ID: 20465866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical techniques for drug detection in oral fluid.
    Lillsunde P
    Ther Drug Monit; 2008 Apr; 30(2):181-7. PubMed ID: 18367978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.